<DOC>
	<DOCNO>NCT00258401</DOCNO>
	<brief_summary>RATIONALE : Eating diet low residue ( fiber , fat , certain milk vegetable product ) may help prevent reduce diarrhea cause pelvic radiation therapy . PURPOSE : This randomized clinical trial study low-residue diet see well work compare dietary intervention treat diarrhea patient undergo radiation therapy pelvis uterine , cervical , prostate cancer .</brief_summary>
	<brief_title>Low-Residue Diet Treating Diarrhea Patients Receiving Pelvic Radiation Therapy .</brief_title>
	<detailed_description>OBJECTIVES : - Compare nutritional status , Common Toxicity Criteria ( CTC ) score , fecal incontinence quality life ( FI-QOL ) patient uterine , cervical , prostate cancer undergo pelvic radiotherapy receive low-residue diet v dietary intervention . - Compare change CTC score FI-QOL patient receive low-residue diet v dietary intervention . - Compare efficacy , term low CTC score high perceived FI-QOL , low-residue diet v dietary intervention patient . OUTLINE : This parallel , randomize , control , pilot study . Patients stratify accord cancer type . Patients randomize 1 2 treatment arm . All patient interview obtain baseline grade diarrhea ( accord NCI 's Common Toxicity Criteria [ CTC ] scale ) dietary history measure Fecal Incontinence Quality Life ( FI-QOL ) . - Arm I ( intervention ) : At onset diarrhea symptom , patient instruct eat low-residue diet . Patients continue diet 2-4 week . They interview weekly 6 week monitor dietary intake , bowel symptom , diarrhea event , FI-QOL , change CTC score . - Arm II ( control ) : Patients undergo dietary intervention interview arm I . PROJECTED ACCRUAL : A total 20 patient accrue study .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Radiation Injuries</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis uterine , cervical , prostate cancer Current patient Ireland/Case Comprehensive Cancer Center Planning pelvic radiation therapy within next 4 month PATIENT CHARACTERISTICS : Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Gastrointestinal No enteric support No inflammatory bowel disease Other No concurrent illness medical condition would preclude study compliance No history allergy dietary intolerance ( e.g. , lactose intolerance ) would preclude study treatment interfere study result PRIOR CONCURRENT THERAPY : Chemotherapy No concurrent chemotherapy Endocrine therapy Concurrent hormonal therapy allow ( e.g. , testosterone suppression ) Radiotherapy See Disease Characteristics Surgery No prior colectomy Other No concurrent glutamine , psyllium , fiber supplement ( e.g. , Benefiber^® Metamucil^® )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>diarrhea</keyword>
	<keyword>radiation toxicity</keyword>
	<keyword>recurrent uterine sarcoma</keyword>
	<keyword>stage I uterine sarcoma</keyword>
	<keyword>stage II uterine sarcoma</keyword>
	<keyword>stage III uterine sarcoma</keyword>
	<keyword>stage IV uterine sarcoma</keyword>
	<keyword>recurrent prostate cancer</keyword>
	<keyword>stage I prostate cancer</keyword>
	<keyword>stage II prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
	<keyword>recurrent cervical cancer</keyword>
	<keyword>stage 0 cervical cancer</keyword>
	<keyword>stage IA cervical cancer</keyword>
	<keyword>stage IB cervical cancer</keyword>
	<keyword>stage IIA cervical cancer</keyword>
	<keyword>stage IIB cervical cancer</keyword>
	<keyword>stage III cervical cancer</keyword>
	<keyword>stage IVA cervical cancer</keyword>
	<keyword>stage IVB cervical cancer</keyword>
</DOC>